symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
QSAM,4.83,2.105772,1435,15880750,0,3.51-6.2,-0.025,"QSAM Biosciences, Inc.",USD,0001310527,US74738N1037,74738N103,Other OTC,PNK,Biotechnology,https://qsambio.com,"QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.",Mr. Douglas R. Baum,Healthcare,US,4,512 343 4558,Plaza 1,Austin,TX,78759,,0,https://financialmodelingprep.com/image-stock/QSAM.png,2012-08-13,False,False,True,False,False
